Unusual gestational choriocarcinoma arising in an interstitial pregnancy.

Choriocarcinoma is a rare malignant gestational trophoblastic tumor. Although it is most commonly due to malignant transformation of a molar pregnancy, it can develop after all types of pregnancy including normal term pregnancy, spontaneous abortion or ectopic pregnancy. 1 However, choriocarcinoma arising in ectopic pregnancy is an extremely rare event. Its incidence is one in 5333 tubal pregnancies and one in 1.6 million normal intrauterine pregnancies. 1 To our knowledge, two cases of choriocarcinoma arising in an interstitial pregnancy were reported in the literature. 2,3 We report here a new case.

Sawsen Meddeb made substantial contributions to conception, design, and acquisition of data. Mohamed Salah Rhim was involved in the analysis and interpretation of data and drafting the article. Wissal Zarrouk participated in drafting the article. Mohamed Bibi critically revised the manuscript. Mohamed Tahar Yacoubi and Hedi Khairi gave final approval of the version to be submitted.

Patient's consent was obtained.

None.

No author has any conflict of interest to declare.

A 46-year-old woman, gravida 4, para 3, was admitted for abdominal pain. She had had an amenorrhea of 7 weeks. Physical examination revealed severe right adnexal pain and tenderness. Transvaginal sonography showed an empty uterus with a thin endometrium and a 3 cm intramural echogenic mass on the left side of the fundus. There was neither fluid in the Douglas pouch, nor adnexal masses nor “ring of fire” signs. Human chorionic gonadotropin (βhCG) was at 6320 mUI/ml. These findings were consistent with ectopic interstitial pregnancy. According to the department's protocol, the patient received a single dose of methotrexate. 4 βhCG decreased to 3010 mUI/ml after one week, then raised to 7020 mUI/ml two weeks later. Therefore, the patient underwent a laparoscopy. A 3 cm mass located on the left side of the uterine fundus was found. The fallopian tubes and ovaries were normal. The mass with portion of myometrium and serosa were excised. Histological examination showed a hemorrhagic infiltration of the myometrium without trophoblastic cells. Thus, a monthly monitoring of plasmatic βhCG level was decided till its negativity. However, earlier to her first appointment, the patient presented in the emergency room with severe acute pelvic pain and vaginal bleeding. Ultra sonography revealed a hyper echoic intrauterine mass and βhCG titer was very high (4,000,000 mUI/ml) suggestive for a persistent trophoblastic disease. Promptly, our patient had unstable hemodynamic status, so she underwent emergency hysterectomy. Histological examination revealed a proliferation of atypical trophoblastic cells, both syncytiotrophoblastic and cytotrophoblastic cells with numerous mitoses. The stroma was hemorrhagic and the tumor cells infiltration is limited to the myometrial wall. There were no placental villi. Thus, the diagnosis of choriocarcinoma was proposed. Imaging investigation of the chest, abdomen and pelvis did not show any metastasis. The patient was treated with 3 cycles of monochemotherapy based on Methotrexate. The patient was followed by βhCG test weekly in the first month, then monthly during the first year. Two years later, she was free from recurrence and metastasis.

Choriocarcinoma is a highly malignant tumor originating in trophoblastic tissue. Usually presents within a hydatidiform mole, it primarily occurs during the procreation period. 1 It is a biphasic malignant proliferation of cytotrophoblast and syncytiotrophoblast without chorial villi. The age has consistently been identified as an important risk factor. Age-specific incidence reports usually reveal a “J curve” and younger 40 have higher rates. 5 Although the tumor may arise from any type of prior gestational events as normal pregnancy or spontaneous abortion, it more frequently complicates hydatidiform mole regardless of its intrauterine or ectopic location. 6 The development of the tumor varies between 5 weeks and 15 years after gestation or even after menopause. 6,7 Its association with ectopic pregnancy is extremely rare and in general with aggressive behavior. Indeed, only 0.76–4% of choriocarcinomas developed in ectopic location. 8,9 Its specific occurrence in interstitial pregnancy is exceptional with, in our knowledge, three cases being reported in the literature including the present one. 2,3 The diagnosis of primary extra-uterine choriocarcinoma is challenging because the clinical symptoms are often nonspecific and can mimic hemorrhagic ovarian cyst, tubo-ovarian abscess, ovarian torsion, and ectopic pregnancy. 10 The frequency of metastatic disease with resultant increased morbidity and mortality is related to the delayed diagnosis. The typical sonographic appearance of intra-uterine choriocarcinoma is a large echogenic irregular mass occupying the uterine cavity, hyper vascularized in color-flow doppler. However, imaging findings are not helpful in extra-uterine location. Serial measurement of βhCG level was the most useful marker of diagnosis and follow up. 11 When nonmetastatic choriocarcinoma occurs in young patients who desire to preserve their fertility, it should be treated by local resection of the tumor followed by chemotherapy. 3 At the new England trophoblastic disease center, all the women with tubal choriocarcinoma (6/6) achieved complete remission with chemotherapy even those with metastases (4/6). 9 The two cases of choriocarcinoma arising in an interstitial pregnancy reported were also successfully treated with chemotherapy based on methotrexate. 2,3

The increasing tendency to treat ectopic pregnancy by conservative management suggests the crucial role of pathological examination associated with βhCG level follow up, not only to diagnose persistent ectopic pregnancy but also to avoid missing malignant trophoblastic disease.